关于论坛

自近期中国药品审批程序改革以来,中国的临床试验和新药审批速度加快。仅在2017年,就有34种医药产品和5种生物技术产品获得批准,创历史新高。它为世界各地的药物开发公司打开了中国市场的大门,并点燃了中国公共制药公司的许可证。

China Focus @ BWB将来自中国的投资者和制药业领导者以及医疗保健创新者聚集在一起,旨在激励,教育和促进来自世界各地的领先生物制药创新的跨境投资和合作。该论坛在论坛之前和期间提供了一流的一对一的交流机会。

为什么参加

学习

了解中国工业领袖在中国日益增长的医疗保健市场机遇,创新和投资趋势

介绍

介绍50多位积极寻求投资和授权机会的中国投资者

项目对接

通过在线宣传和1对1会议,在论坛之前和期间与投资者联系

机遇

通过海外的额外机会,提升您对2019年的愿景

INDUSTRIES OF FOCUS

Immunotherapy

PD-(L)1

CAR-T

TCR-T

Tumor Vaccine

Oncolytic Virus

end

 

Gene Therapy and Genetic Test

 

Rare Disease Gene Therapy

CRISPA

Genetic Test

 

 

 

AI in Pharma and Healthcare

 

Diagnostics

New drug development

 

 

end

参与的中国公司

科伦制药

Livzon Mabpharm

齐鲁制药

正大天晴

GenFleet Therapeutics

CARsgen Therapeutics

齐鲁细胞疗法

复星医药

恒瑞治疗公司

Accelerate NY Seed Fund

Delos Capital

红杉资本

F-Prime Capital Partners

礼来亚洲基金

Ankebio

Sino Pharm

XtalPi

Shanghai Junshi Biosciences

Wuxi Apptec

Ascletis Pharmaceuticals

Kaitai Capital

Leking Wellness

Haiyao

Lee's Pharmaceutical Holdings Ltd.

Livzon Pharmaceutical Group

Luye Pharma

SanBao Group Co. Ltd.

3SBio Inc.

Hrain Biotechnology

Yuyan Bio

Wuhan Bio-Raid Biotechnology Co., Ltd

Cellular Biomedicine Group

Simcere Pharmaceutical Group

Xiangxue Group

Yabao Pharmaceutical Group Co. Ltd.

JW Therapeutics (Shanghai) Co. Ltd.

Kelun Phamacetical

Eddingpharm Inc.

Galaxy Biopharma

Unicar-Therapy Biomedicine

Oriza Holdings

Yuanming Capital

AVIC Capital Co., Ltd.

Jolly Pharmaceutical

特邀发言人

Zonghai Li

CEO&CSO, CARsgen Therapeutics

Zhaolong Gong

CEO, 3D Medcare

Qiang Lu

Chairman, Genfleet Pharmaceutical

Lynn Yang

Managing Director, Sequoia Capital China

Ai-Min Hui (TBD)

CMO, Fosun Pharma

John Chen

Director of Business Development, Livzon Mabpharm, Inc

Rebecca Robbins

Business Reporter, STAT News

Anjiang (Vincent) Liu

Senior Advisor, Fosun Pharma

Yuanhua Ding

Head of External R&D Innovation – Asia, Pfizer Worldwide Research & Development

Noel Goddard

Principal, Accelerate NY Seed Fund

Kim Nearing

Managing Director, Cedrus Group

Bob Ai

Senior Vice President , Solebury Trout

Chong Xu

Senior Associate, F-Prime Capital Partners

Tim Xiao

Principal at Delos Capital

Ginger Ding

Director of Research, MyBioGate

Feng Tian

Chief scientific Officer, Ambrx

Jinming Gu

Head of Biologics Development at Abpro labs;
Former Executive Director of Biologics Discovery at Shanghai HengRui Pharmaceuticals

Zhenhua Wu

CEO, NeuExcell Therapeutics

Miguel Forte

CEO, Zelluna Immunotherapy;
Chair, Commercialization Committee at ISCT

Stefanos Theoharis

SVP Corporate Development and Partnering, Cell Medica

Zonghai Li

CEO&CSO, CARsgen Therapeutics

Zhinan Xia

Founder and CSO, Abimmune Bio
Previous Director, Synageva BioPharma Corp.

演示、直接介绍、促进会议等

为何选择

提高公司的知名度,并吸引来自中国顶级制药和投资公司的50多位活跃的BD高管的兴趣

直接介绍潜在的合作伙伴

获得中国投资者的反馈,将您的战略与不断增长的中国市场结合起来

展示公司展示哪些内容

公司演示10分钟的PowerPoint 幻灯片

成为系统精选的合作伙伴

直接向至少5家顶级风险投资公司,制药公司和私募股权投资者介绍

促进合作会议一对一咨询,帮助您将潜在合作伙伴列入候选名单,直接介绍和安排会议。确保至少10次会议对接

中国与参会者的完整列表及其联系信息

Apply to Present

Sept 4th 10:00-12:00 Registration
1:30-5:00 Opening Remarks
Keynote: New Drugs to Enter  China under CFDA Reform: Opportunities and Challenges

Dr. Ruyi He, Chief Scientist, Center for Drug Evaluation, CFDA

Keynote: China Innovation in Immunotherapy
Panel Discussion: Chinese Big Pharma’s strategy in Drug Development and Commercialization Collaboration
Panel Discussion: Cross-border Investment and Collaboration under the US-China Trade Friction
Sept 5th 8:00 - 10:00 1-to-1 partnering meetings
10:00 -12:00 pm Technical Track: Sector Spotlight, Industry Map and Company Pitch

  • CAR-T and TCR-T
12:00 pm - 1:30 pm Lunch Break and 1-to-1 partnering meetings
1:30 pm - 5:00 pm Technical Track: Sector Spotlight, Industry Map and Company Pitch

  • PD-(L)1 Combined Therapies
  • Gene Therapy for Rare Disease
5:00 pm - 6:00 pm 1-to-1 partnering meetings
Sept 6th 8:00 - 5:00 pm 1-to-1 partnering meetings
Sept 7th   VIP Meetings

活动场地

Hynes Convention Center, Room 102

900 Boylston St
Boston, MA 02115

徽章收藏

登记处位于广场层的海因斯会议中心的主大厅。您将收到一封包含机票条形码的电子邮件。为了加快您的注册登记流程,请打印此条形码确认信息或将其带到您的移动设备上。

报名时间

9月4日星期二 - 上午8:00至下午5:00

9月5日星期三 - 上午7:30至下午7:30

9月6日星期四 - 上午7:00至下午5:30

REGISTER NOW

China Focus@BWB Forum, including:

  • One account to our 1-to-1 meeting system, access to sending 1-to-1 meetings to all attendees
  • Forum access to September 4-6

Early Bird(Before July 31):$349

Regular Price(August 1 to September 4):$499

现在注册

China Focus@BWB 论坛, 包括:

注册 详情 早鸟价

(7月31号前)

常规价
China Focus@BWB 包括:

合作系统帐户

访问China Focus @ BWB的所有论坛会议

$349 $499
BWB全通道 包括China Focus @ BWB并访问以下活动:

BioProcess International Conference & Exhibition

Cell & Gene Therapy Bioprocessing & Commercialization

Microbiome Therapeutics US

Al Applications for Drug Discovery and Development

Cell & Gene Connect

BioPharma America

$4,199

Agenda

Sept 4th

10:00-12:00

  • Registration

1:30-5:00

  • Opening Remarks
    • Keynote: China’s FDA reform – Opportunities for Novel Drugs to Enter China
    • Keynote: China Innovation in Immunotherapy
    • Panel Discussion: Chinese Big Pharma’s strategy in Drug Development and Commercialization Collaboration
    • Panel Discussion: Cross-border Investment and Collaboration under the US-China Trade Friction

Sept 5th

8:00 am – 10:00 am

  • 1-to-1 partnering meetings

10:00 am -12:00 pm

  • Technical Track: Sector Spotlight, Industry Map and Company Pitch
    • CAR-T and TCR-T

12:00 pm – 1:30 pm

  • Lunch Break and 1-to-1 partnering meetings

1:30 pm – 5:00 pm

  • Technical Track: Sector Spotlight, Industry Map and Company Pitch
    • PD-(L)1 Combined Therapies
    • Gene Therapy for Rare Disease

5:00 pm – 6:00 pm

  • 1-to-1 partnering meetings

Sept 6th

8:00 – 5:00 pm

  • 1-to-1 partnering meetings

Sept 7th

  • VIP Meetings

联系我们

赞助

 

李昕欣

手机:+1-713-814-5022

邮箱:xinxin.li@mybiogate.com

注册

 

郑飞凡

手机:+1-713-814-5022

邮箱:feifan.zheng@mybiogate.com